siRNA / miRNA gene silencing Human U937 MK2 (MAPK Kinase 2)

- Found 6301 results

Get tips on using Rac1/2/3 Antibody #2465 to perform Western blotting Rac1

Products Cell Signaling Technology Rac1/2/3 Antibody #2465

Get tips on using ErbB2 (HER-2) Antibody Cocktail to perform Western blotting HER2

Products Thermo Fisher Scientific ErbB2 (HER-2) Antibody Cocktail

Get tips on using EpiTect 96 Bisulfite Kit (2) to perform Bisulfite DNA Modification Fluids

Products Qiagen EpiTect 96 Bisulfite Kit (2)

Get tips on using FaqI (BsmFI) (2 U/µL) to perform Restriction Enzymes BsmFI / FaqI

Products Thermo Fisher Scientific FaqI (BsmFI) (2 U/µL)

Get tips on using BspPI (AlwI) (2 U/µL) to perform Restriction Enzymes AlwI / BspPI

Products Thermo Fisher Scientific BspPI (AlwI) (2 U/µL)

Get tips on using TIMP-2 Antibody (B-12): sc-365671 to perform Western blotting TIMP-2

Products Santa Cruz Biotechnology TIMP-2 Antibody (B-12): sc-365671

Get tips on using Mouse BMP-2 PicoKine™ ELISA Kit to perform ELISA Mouse - BMP-2

Products BosterBio Mouse BMP-2 PicoKine™ ELISA Kit

Get tips on using Rat BMP-2 PicoKine™ ELISA Kit to perform ELISA Rat - BMP-2

Products BosterBio Rat BMP-2 PicoKine™ ELISA Kit
Ne Caco-2 Experiment

Cellular assays Ne Caco-2

A key signature for necrotic cells is the permeabilization of the plasma membrane. Necrosis can be quantified by several cellular and biochemical assays. When studied minutely, it reveals the difficulty in confirmation in secondary induction of necrosis in apoptotic cells. Apoptotic cells are being analyzed to shift to necrotic status owing to membrane permeability at later stages, and thus, discrimination of two cell death becomes critical. Therefore, it is crucial to use a necrosis detection kit or a defined procedure to analyze this unprogrammed form of death in response to immense chemical and physical insults.

Cellular assays Necrosis MIA PaCa-2

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms